Vitadio
PrivateLast Round
Series A
Sep 25, 2023
Total Funding Raised
$4.26M
Company Overview
Vitadio is a medtech company that develops prescription digital therapeutics for lifestyle-related conditions such as type 2 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Patient Engagement, Telemedicine, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Government Contracts, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vitadio Comparables
Compare Vitadio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Perfood GmbH | 85% | |
| Liva Healthcare | 83% | |
| MiGuide | 82% | |
Vitadio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 25, 2023 | ||||
| Seed | Apr 22, 2020 |
Vitadio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| N1 | Seed |
| Pilulka Lab | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 25, 2023
$3.18M round led by Theras Group
- Apr 22, 2020
$1.08M round led by N1 and Pilulka Lab
Vitadio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vitadio's valuation, stock price, and market status.